Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
Certara (NASDAQ: CERT), a global leader in model-informed drug development, has scheduled its Q2 2025 earnings release for August 6th, 2025, after market close. The company will host a conference call at 5:00 PM ET to discuss the financial results.
Investors must pre-register online to participate in the conference call, with registration recommended at least one day in advance. Both a live and archived webcast will be accessible through Certara's investor relations website at ir.certara.com.
Certara (NASDAQ: CERT), leader mondiale nello sviluppo di farmaci basato su modelli, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per il 6 agosto 2025, dopo la chiusura dei mercati. L'azienda terr脿 una conference call alle 17:00 ET per discutere i risultati finanziari.
Gli investitori devono registrarsi online in anticipo per partecipare alla conference call, si consiglia la registrazione almeno un giorno prima. Sia la diretta che la registrazione saranno disponibili sul sito delle relazioni con gli investitori di Certara all'indirizzo ir.certara.com.
Certara (NASDAQ: CERT), l铆der global en desarrollo de medicamentos basado en modelos, ha programado la publicaci贸n de sus resultados del segundo trimestre de 2025 para el 6 de agosto de 2025, despu茅s del cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia a las 5:00 PM ET para analizar los resultados financieros.
Los inversores deben registrarse en l铆nea previamente para participar en la llamada, recomend谩ndose hacerlo al menos un d铆a antes. Tanto la transmisi贸n en vivo como la grabaci贸n estar谩n disponibles en el sitio web de relaciones con inversores de Certara en ir.certara.com.
Certara (NASDAQ: CERT)電� 氇嵏 旮半皹 鞁犾暯 臧滊皽 攵勳暭鞚� 旮�搿滊矊 靹犽憪欤检瀽搿�, 2025雲� 2攵勱赴 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 6鞚� 鞛� 毵堦皭 頉勳棎 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� 鞛 瓴瓣臣毳� 雲检潣頃橁赴 鞙勴暣 霃欕秬鞁滉皠 鞓ろ泟 5鞁�鞐� 旎嵓霟办姢 旖滌潉 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� 旎嵓霟办姢 旖� 彀胳棳毳� 鞙勴暣 靷爠鞐� 鞓澕鞚� 霌彪鞚� 頃挫暭 頃橂┌, 斓滌唽 頃橂（ 鞝� 霌彪鞚� 甓岇灔頃╇媹雼�. 靸濎瓿� 氚� 雲鬼檾霅� 鞗轨簮鞀ろ姼電� Certara 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼 ir.certara.com鞐愳劀 鞚挫毄頃� 靾� 鞛堨姷雼堧嫟.
Certara (NASDAQ : CERT), leader mondial du d茅veloppement de m茅dicaments bas茅 sur des mod猫les, a programm茅 la publication de ses r茅sultats du deuxi猫me trimestre 2025 pour le 6 ao没t 2025, apr猫s la cl么ture des march茅s. La soci茅t茅 tiendra une conf茅rence t茅l茅phonique 脿 17h00 ET pour discuter des r茅sultats financiers.
Les investisseurs doivent s'inscrire en ligne 脿 l'avance pour participer 脿 la conf茅rence t茅l茅phonique, une inscription au moins un jour avant est recommand茅e. Une diffusion en direct ainsi qu'un webcast archiv茅 seront accessibles via le site des relations investisseurs de Certara 脿 l'adresse ir.certara.com.
Certara (NASDAQ: CERT), ein weltweit f眉hrendes Unternehmen im modellbasierten Arzneimittelentwicklungsbereich, hat die Ver枚ffentlichung der Ergebnisse f眉r das zweite Quartal 2025 f眉r den 6. August 2025 nach B枚rsenschluss geplant. Das Unternehmen wird um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Finanzergebnisse zu besprechen.
Investoren m眉ssen sich online vorab registrieren, um an der Telefonkonferenz teilzunehmen, eine Registrierung mindestens einen Tag im Voraus wird empfohlen. Sowohl ein Live- als auch ein Archiv-Webcast sind 眉ber die Investor-Relations-Website von Certara unter ir.certara.com zug盲nglich.
- None.
- None.
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, August 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the 鈥淚nvestors鈥� section of the Certara website at .
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.聽Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
Media Contact:
Alyssa Horowitz
FAQ
When will Certara (CERT) release Q2 2025 earnings?
What time is Certara's Q2 2025 earnings call?
How can investors join Certara's Q2 2025 earnings call?
Where can I access Certara's Q2 2025 earnings webcast?
